SlideShare a Scribd company logo
1 of 26
Download to read offline
UNIT: IV
CPCSEA Guidelines for
Laboratory animal facility
Presented & Written By: *Rahul Pal, Prachi Pandey
M. Pharm (Pharmaceutics).
*Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur,
Rajasthan, 303121, India.
B
I
O
S
T
A
T
I
S
T
I
C
S
*RahulPal, Prachi Pandey
Master’sof Pharmacy(M. Pharm)
“Pharmaceutics”
“COVERED SYLLABUS”
“CPCSEA guidelines for laboratory animal
facility”: Goals, veterinary care, quarantine,
surveillance, diagnosis, treatment and control of
disease, personal hygiene, location of animal
facilities to laboratories, anesthesia, euthanasia,
physical facilities, environment, animal
husbandry, record keeping, SOPs, personnel and
training, transport of lab animals.
INTRODUCTION
 “CPCSEA” stands for, The Committee for the Purpose of Control
and Supervision of Experiments on Animals.
 It was originally established in 1964, under the Prevention of
Cruelty to Animals (PCA) Act, 1960.
 In 2022, the name of the committee was changed to the Committee
for Control and Supervision of Experiments on Animals (CCSEA).
 Under the dedicated leadership of Ms. Maneka Gandhi.
GOALS
› The CPCSEA's primary goal is to promote the humane treatment of
animals used in research, education, and testing.
› Minimizing animal suffering.
› Ensuring scientific validity and quality.
› Fostering transparency and accountability.
› Building a collaborative environment.
VETERINARY CARE
Veterinary care plays a crucial role in upholding the CPCSEA's goal.
The committee emphasizes several key aspects of veterinary care:
› Qualified supervision.
› Preventive measures.
› Humane procedures: Pain management and Euthanasia.
› Recordkeeping.
› Collaboration with researchers.
Veterinary care is an integral part of the CPCSEA's framework for
ensuring animal welfare in research.
QUARANTINE
It involves the isolation of newly acquired animals from the existing
animal population for a specific period. This serves several important
purposes:
1. Disease prevention: Unknown pathogens.
2. Acclimatization and stabilization: New environments can be
stressful for animals, Stabilizes physiological and psychological
factors.
3. Minimizing cross-contamination.
By implementing quarantine protocols, the committee able to create a
responsible and sustainable environment for animal research.
SURVEILLANCE
Surveillance plays a pivotal role in the CPCSEA's mission to ensure
animal welfare and uphold ethical research practices. It involves the
systematic observation and monitoring of animals.
To identify any potential health problems, distress, or deviations
from expected behavior. The several key aspects of surveillance under
CPCSEA include:
› Daily observations.
› Environmental monitoring.
› Body weight and condition scoring.
› Behavioral observations.
› Recordkeeping and data analysis.
DIAGNOSIS
Diagnosis plays a crucial role in ensuring animal welfare and upholding ethical
research practices. It involves identifying the cause of an animal's illness or
distress.
The several aspects of diagnosis under CPCSEA include:
 Clinical examination.
 Diagnostic tests: Blood tests, imaging techniques like X-rays or ultrasound.
 Differential diagnosis.
 Consulting specialists.
 Animal welfare considerations.
 Documenting the diagnosis.
By promoting effective diagnostic practices, the CPCSEA strives to ensure that
animals used in research receive timely and accurate medical attention.
TREATMENT AND CONTROL OF
DISEASE
CPCSEA extends to the effective treatment and control of diseases
within animal facilities.
The various steps how CPCSEA guidelines address this crucial
aspect:
1. Proactive Disease Prevention.
2. Prompt Diagnosis and Treatment.
3. Hygiene and Sanitation.
4. Recordkeeping and Reporting.
5. Collaboration and Training: Veterinarians/researchers,
Training of animal caring staff.
CONT…
PROACTIVE DISEASE
PREVENTION
› Vaccination
› Parasite control
› Nutritional management
› Environmental enrichment
PROMPT DIAGNOSIS
AND TREATMENT
› Daily monitoring
› Qualified veterinary care
› Appropriate medication
› Pain management
› Isolation and quarantine
PERSONAL HYGIENE
Maintaining high standards of personal hygiene is an essential aspect of
animal welfare under the CPCSEA. This not only protects the animals
from potential infections but also ensures the validity of research data.
The various aspects for personal hygiene as followings:
› Clean clothing, footwear and Hand hygiene.
› Jewellery and accessories.
› Eating, drinking, smoking, hair and beard.
› Protective equipment, Training and awareness.
› Facilities and supplies.
The CPCSEA aims to foster a culture of personal hygiene within animal
research facilities.
LOCATION OF ANIMAL
FACILITIES TO LABORATORIES
The CPCSEA lays down specific guidelines for the location of animal
facilities relative to laboratories. This aims to minimize stress, noise,
and other disturbances for the animals while ensuring research integrity
and practicality. The various key requirements:
1) Physical Separation: Separate building, wing, floor, or room,
Distance from disturbance.
2) Dedicated Access: Separate pathways, entrances and controlled
access points.
3) Environmental Considerations: Natural light, ventilation,
Temperature, humidity control and noise reduction.
4) Additional Guidelines: Waste disposal, Security and emergency
preparedness.
ANESTHESIA
Anesthesia plays a crucial role in achieving goal by ensuring animals are
pain-free and unconscious during painful procedures or surgeries. The
CPCSEA lays down specific guidelines for the use of anesthesia in
animals:
› Justification and minimization.
› Qualified personnel.
› Pre-anesthetic assessment, Appropriate anesthetic agents and dosages.
› Pain management: An integral part of anesthesia.
› Monitoring and recordkeeping.
› Recovery and post-operative care.
› Training and education.
CONT…
Anesthesia is a controlled, temporary state of unconsciousness,
painlessness, and muscle relaxation induced in animals through
medication. The different types of anesthesia can be used in animals,
including:
a) General anesthesia: This induces complete unconsciousness and
muscle relaxation, often through inhaled gases or injectable
medications.
b) Local anesthesia: This numbs a specific area of the body, allowing
for procedures on that area while the animal remains conscious.
c) Regional anesthesia: This numbs a larger area of the body, such as
a limb, while the animal remains conscious or lightly sedated.
Species: Rodent (rat or mouse)
Procedure: Tissue collection
Agent: Ketamine/xylazine
combination (injectable)
Dosage: Ketamine 80-100
mg/kg, xylazine 5-10 mg/kg,
both given intraperitoneally
Species: Rabbit
Procedure: Dental cleaning
Agent: Propofol (injectable)
Dosage: 5-10 mg/kg
intravenous bolus, followed by
a maintenance infusion of 1-5
mg/kg/hr
Species: Cat
Procedure: Ovariohysterectomy
(spaying)
Agent: Ketamine (injectable) and
medetomidine (injectable)
Dosage: Ketamine 5-10 mg/kg,
medetomidine 0.05-0.1 mg/kg, both
given intramuscularly
Species: Horse
Procedure: Colic surgery
Agent: Sevoflurane (inhaled gas)
and epidural analgesia (local
anesthetic)
Dosage: Sevoflurane 1-3% in
oxygen, epidural bupivacaine 0.5-
1.0 ml/segment
Species: Dog
Procedure: Neutering
Agent: Isoflurane (inhaled gas)
Dosage: 1-3% isoflurane in
oxygen, adjusted based on
individual response
SPECIFIED
E
X
A
M
P
L
E
S
EUTHANASIA
Euthanasia refers to the intentional act of ending an animal's life to relieve
suffering or prevent further pain.
Purpose: The euthanasia having several purposes as followings:
› Painless death.
› Relief from suffering.
› Population control.
Euthanasia is a sensitive and ethical decision.
Methods: Various methods can be employed for euthanasia. These are like:
Overdose of anesthetic agents, Cervical dislocation, Carbon dioxide (CO2)
inhalation and barbiturate injection or electrocution.
PHYSICAL FACILITIES
CPCSEA to ensure the animals' physical and mental well-being,
minimizing stress and promoting their health and comfort.
The various key aspects of physical facilities for animals under CPCSEA:
› Caging and housing.
› Environmental sanitation and hygiene.
› Food and water: Nutritious diet, Fresh water.
› Veterinary care.
› Recordkeeping.
Animal facilities can create a safe, comfortable, and stimulating
environment for animals used in research.
ENVIRONMENT
CPCSEA recognizes the importance of a stimulating and stress-free
environment for animals used in research.
The key aspects of environment for animals under CPCSEA:
1. Sensory stimulation.
2. Social interaction.
3. Choice and control.
4. Species-specific considerations.
5. Regular monitoring and evaluation.
These guidelines for environmental enrichment to promote the animals'
physical and mental well-being.
ANIMAL HUSBANDRY
Animal husbandry practices for animals used in research fall under the
strict guidelines of the CPCSEA. These guidelines aim to ensure ethical
treatment, good welfare, and minimal suffering for animals throughout
their involvement in research.
How animal husbandry practices are addressed under CPCSEA:
› Housing and environment: Species-specific, temp. Humidity and
Lighting cycles
› Food and water
› Hygiene and sanitation
› Veterinary care and record keeping.
RECORD KEEPING
The Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA) places great emphasis on
meticulous record keeping throughout all stages of animal
research.
› Detailed records: Maintain detailed records of all animal care
procedures, including housing conditions, diet, veterinary
care, observations, and any abnormalities. This ensures proper
monitoring and animal well-being.
› Animal identification: Each animal should have proper
identification tags or other methods to track individual health and
well-being.
SOPs
CPCSEA emphasizes the importance of standardized procedures to ensure the
ethical treatment and welfare of animals in research. These SOPs cover various
aspects of animal care and use, from housing and husbandry to experimental
procedures and recordkeeping. The key areas where SOPs are crucial under
CPCSEA guidelines:
› Animal Acquisition and Housing
› Institutional Animal Ethics Committee (IAEC).
› Animal Housing and Husbandry.
› Animal Experimentation: For drugs, emergency protocols etc.
› Recordkeeping and Documentation.
SOPs are not static documents. They should be regularly reviewed, updated, and
adapted based on new scientific knowledge, changes in animal welfare best
practices, and evolving regulatory requirements.
CONT…
› SOPs stands for Standard Operating Procedures. These are
detailed, step-by-step instructions that outline how specific tasks
related to animal care and use should be carried out.
› They are essential for ensuring the consistent, ethical, and humane
treatment of animals throughout their involvement in research.
PERSONNELAND TRAINING
The CPCSEA recognizes the crucial role of qualified and well-trained personnel
in ensuring the ethical treatment and well-being of animals used in research.
These individuals are responsible for various aspects of animal care, from
husbandry and handling to experimental procedures and recordkeeping.
› Qualifications and experience: Animal care personnel, Researchers and
technicians and Veterinarians.
› Training requirements: Regular refresher training and Specialized Training.
› Training content and delivery.
Qualified and well-trained personnel are not just an expense but an investment in
ethical research and animal welfare.
TRANSPORT OF LAB ANIMALS
The transport of laboratory animals brings unique challenges and ethical
considerations. Ensuring their safety, comfort, and well-being during
transportation is crucial. CPCSEA outlines specific guidelines to ensure
responsible and humane practices in this process.
The various key aspects to consider for the transport of lab animals under
CPCSEA:
 Planning and preparation.
 Transportation containers and environment.
 Animal handling and care.
 Post-transport care.
 Adherence to regulations.
Responsible transport of lab animals requires careful planning, adherence to
ethical principles, and prioritizing animal welfare throughout the process.
REFERECES
1. Committee for the Purpose of Control and Supervision on Experiments
on Animals. (2003). CPCSEA Guidelines for laboratory animal
facility. Indian J Pharmacol, 35(4), 257-274.
2. Mahesh, N. M. IMPACT OF ‘CPCSEA’GUIDELINES ON
LABORATORY ANIMALS USE.
3. Pereira, S., Veeraraghavan, P., Ghosh, S., & Gandhi, M. (2004). Animal
experimentation and ethics in India: the CPCSEA makes a
difference. Alternatives to laboratory animals, 32(1_suppl), 411-415.
4. Qadri, S. S., & Ramachandra, S. G. (2018). Laws, regulations, and
guidelines governing research animal care and use in India.
In Laboratory animals (pp. 237-261). Academic Press.
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Laboratory animal facility.pptx

More Related Content

What's hot

regulatory requirement for bioequivalence
regulatory requirement for bioequivalenceregulatory requirement for bioequivalence
regulatory requirement for bioequivalencelamrin33
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Aakashdeep Raval
 
Documentation clinical trial
Documentation clinical trialDocumentation clinical trial
Documentation clinical trialankit sharma
 
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
 INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)Turacoz Skill Development Program
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safetyAzierta
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsDr. Siddhartha Dutta
 
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator MOHAMMEDSALEEMJM
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug ApplicationSuhas Reddy C
 
ba be studies
ba be studiesba be studies
ba be studiesRohit K.
 
Declaration of-helsinki presantation
Declaration of-helsinki presantationDeclaration of-helsinki presantation
Declaration of-helsinki presantationManoharReddy183
 
Choice of control group in clinical trials
Choice of control group in clinical trialsChoice of control group in clinical trials
Choice of control group in clinical trialsNagendra SR
 
Institutional review board by akshdeep sharma
Institutional review board by akshdeep sharmaInstitutional review board by akshdeep sharma
Institutional review board by akshdeep sharmaAkshdeep Sharma
 
Indian gcp guidelines[647]
Indian gcp guidelines[647]Indian gcp guidelines[647]
Indian gcp guidelines[647]AkhileshAkki6
 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Prachi Pandey
 
Safety monitoring in clinical trails
Safety monitoring in clinical trailsSafety monitoring in clinical trails
Safety monitoring in clinical trailsGOURIPRIYA L S
 

What's hot (20)

regulatory requirement for bioequivalence
regulatory requirement for bioequivalenceregulatory requirement for bioequivalence
regulatory requirement for bioequivalence
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
 
Documentation clinical trial
Documentation clinical trialDocumentation clinical trial
Documentation clinical trial
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
 
Herbal regulation
Herbal regulationHerbal regulation
Herbal regulation
 
Investigator brochure
Investigator brochureInvestigator brochure
Investigator brochure
 
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
 INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safety
 
Schedule y
Schedule  ySchedule  y
Schedule y
 
CLINICAL TRIAL PROTOCOL
CLINICAL TRIAL PROTOCOLCLINICAL TRIAL PROTOCOL
CLINICAL TRIAL PROTOCOL
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
 
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug Application
 
ba be studies
ba be studiesba be studies
ba be studies
 
Declaration of-helsinki presantation
Declaration of-helsinki presantationDeclaration of-helsinki presantation
Declaration of-helsinki presantation
 
Choice of control group in clinical trials
Choice of control group in clinical trialsChoice of control group in clinical trials
Choice of control group in clinical trials
 
Institutional review board by akshdeep sharma
Institutional review board by akshdeep sharmaInstitutional review board by akshdeep sharma
Institutional review board by akshdeep sharma
 
Indian gcp guidelines[647]
Indian gcp guidelines[647]Indian gcp guidelines[647]
Indian gcp guidelines[647]
 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
 
Safety monitoring in clinical trails
Safety monitoring in clinical trailsSafety monitoring in clinical trails
Safety monitoring in clinical trails
 

Similar to Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Laboratory animal facility.pptx

Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines Parul Institute of Pharmacy
 
CPCSEA guidelines ppt
CPCSEA guidelines pptCPCSEA guidelines ppt
CPCSEA guidelines pptDhruviParmar
 
Pharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptxPharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptxabhiirode
 
Cpcsea guidelines
Cpcsea guidelines Cpcsea guidelines
Cpcsea guidelines Praba karan
 
introduction Bio ethics and preclinical and clinical trial by srota dawn
introduction Bio ethics and preclinical and clinical trial by srota dawnintroduction Bio ethics and preclinical and clinical trial by srota dawn
introduction Bio ethics and preclinical and clinical trial by srota dawnSrota Dawn
 
Ethical issues related to animal biotechnology
Ethical issues related to animal biotechnologyEthical issues related to animal biotechnology
Ethical issues related to animal biotechnologyKAUSHAL SAHU
 
CPCSEA GUIDELINE .pptx
CPCSEA GUIDELINE .pptxCPCSEA GUIDELINE .pptx
CPCSEA GUIDELINE .pptxRajat Singh
 
Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA MANIKANDAN V
 
CPCSEA Guidelines
CPCSEA GuidelinesCPCSEA Guidelines
CPCSEA GuidelinesRuchiPal10
 
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptxGLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptxHasiful Arabi
 

Similar to Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Laboratory animal facility.pptx (20)

Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
 
CPCSEA .pptx
CPCSEA .pptxCPCSEA .pptx
CPCSEA .pptx
 
CPCSEA Guidelines
CPCSEA GuidelinesCPCSEA Guidelines
CPCSEA Guidelines
 
CPCSEA guidelines ppt
CPCSEA guidelines pptCPCSEA guidelines ppt
CPCSEA guidelines ppt
 
Animal care and ethics
Animal care and ethicsAnimal care and ethics
Animal care and ethics
 
Pharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptxPharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptx
 
CPCSEA By UNMESH.pptx
CPCSEA By UNMESH.pptxCPCSEA By UNMESH.pptx
CPCSEA By UNMESH.pptx
 
Cpcsea guidelines
Cpcsea guidelines Cpcsea guidelines
Cpcsea guidelines
 
introduction Bio ethics and preclinical and clinical trial by srota dawn
introduction Bio ethics and preclinical and clinical trial by srota dawnintroduction Bio ethics and preclinical and clinical trial by srota dawn
introduction Bio ethics and preclinical and clinical trial by srota dawn
 
Cpcsea
CpcseaCpcsea
Cpcsea
 
Ethical issues related to animal biotechnology
Ethical issues related to animal biotechnologyEthical issues related to animal biotechnology
Ethical issues related to animal biotechnology
 
CPCSEA GUIDELINE .pptx
CPCSEA GUIDELINE .pptxCPCSEA GUIDELINE .pptx
CPCSEA GUIDELINE .pptx
 
Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA
 
CPCSEA.pptx
CPCSEA.pptxCPCSEA.pptx
CPCSEA.pptx
 
Cpcsea presentation
Cpcsea presentation Cpcsea presentation
Cpcsea presentation
 
CPCSEA Guidelines
CPCSEA GuidelinesCPCSEA Guidelines
CPCSEA Guidelines
 
CPCSEA
CPCSEACPCSEA
CPCSEA
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptxGLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
 

More from Prachi Pandey

Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxPrachi Pandey
 
Niosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxNiosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxPrachi Pandey
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...Prachi Pandey
 
The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...Prachi Pandey
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...Prachi Pandey
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfPrachi Pandey
 
Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Prachi Pandey
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPrachi Pandey
 
Partition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPartition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPrachi Pandey
 
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...Prachi Pandey
 
ProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxPrachi Pandey
 
MicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxMicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxPrachi Pandey
 
Protein and Peptide.pptx
Protein and Peptide.pptxProtein and Peptide.pptx
Protein and Peptide.pptxPrachi Pandey
 
NanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfNanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfPrachi Pandey
 
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxTOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxPrachi Pandey
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxPrachi Pandey
 
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptxBiostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptxPrachi Pandey
 
introductiontopharmacy-231014060238-2ac16fdc.pdf
introductiontopharmacy-231014060238-2ac16fdc.pdfintroductiontopharmacy-231014060238-2ac16fdc.pdf
introductiontopharmacy-231014060238-2ac16fdc.pdfPrachi Pandey
 
medicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdf
medicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdfmedicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdf
medicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdfPrachi Pandey
 

More from Prachi Pandey (20)

Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
 
Niosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxNiosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptx
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); Advanceme...
 
The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
 
Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
 
Partition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPartition Coefficient Determination.pptx
Partition Coefficient Determination.pptx
 
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
 
ProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptx
 
IMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptxIMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptx
 
MicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxMicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptx
 
Protein and Peptide.pptx
Protein and Peptide.pptxProtein and Peptide.pptx
Protein and Peptide.pptx
 
NanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfNanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdf
 
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxTOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptx
 
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptxBiostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
 
introductiontopharmacy-231014060238-2ac16fdc.pdf
introductiontopharmacy-231014060238-2ac16fdc.pdfintroductiontopharmacy-231014060238-2ac16fdc.pdf
introductiontopharmacy-231014060238-2ac16fdc.pdf
 
medicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdf
medicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdfmedicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdf
medicalresearch-research-methodologybiostatistics-231028034159-d884bb5e.pdf
 

Recently uploaded

Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 

Recently uploaded (20)

Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 

Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Laboratory animal facility.pptx

  • 1. UNIT: IV CPCSEA Guidelines for Laboratory animal facility Presented & Written By: *Rahul Pal, Prachi Pandey M. Pharm (Pharmaceutics). *Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, 303121, India. B I O S T A T I S T I C S *RahulPal, Prachi Pandey Master’sof Pharmacy(M. Pharm) “Pharmaceutics”
  • 2. “COVERED SYLLABUS” “CPCSEA guidelines for laboratory animal facility”: Goals, veterinary care, quarantine, surveillance, diagnosis, treatment and control of disease, personal hygiene, location of animal facilities to laboratories, anesthesia, euthanasia, physical facilities, environment, animal husbandry, record keeping, SOPs, personnel and training, transport of lab animals.
  • 3. INTRODUCTION  “CPCSEA” stands for, The Committee for the Purpose of Control and Supervision of Experiments on Animals.  It was originally established in 1964, under the Prevention of Cruelty to Animals (PCA) Act, 1960.  In 2022, the name of the committee was changed to the Committee for Control and Supervision of Experiments on Animals (CCSEA).  Under the dedicated leadership of Ms. Maneka Gandhi.
  • 4. GOALS › The CPCSEA's primary goal is to promote the humane treatment of animals used in research, education, and testing. › Minimizing animal suffering. › Ensuring scientific validity and quality. › Fostering transparency and accountability. › Building a collaborative environment.
  • 5. VETERINARY CARE Veterinary care plays a crucial role in upholding the CPCSEA's goal. The committee emphasizes several key aspects of veterinary care: › Qualified supervision. › Preventive measures. › Humane procedures: Pain management and Euthanasia. › Recordkeeping. › Collaboration with researchers. Veterinary care is an integral part of the CPCSEA's framework for ensuring animal welfare in research.
  • 6. QUARANTINE It involves the isolation of newly acquired animals from the existing animal population for a specific period. This serves several important purposes: 1. Disease prevention: Unknown pathogens. 2. Acclimatization and stabilization: New environments can be stressful for animals, Stabilizes physiological and psychological factors. 3. Minimizing cross-contamination. By implementing quarantine protocols, the committee able to create a responsible and sustainable environment for animal research.
  • 7. SURVEILLANCE Surveillance plays a pivotal role in the CPCSEA's mission to ensure animal welfare and uphold ethical research practices. It involves the systematic observation and monitoring of animals. To identify any potential health problems, distress, or deviations from expected behavior. The several key aspects of surveillance under CPCSEA include: › Daily observations. › Environmental monitoring. › Body weight and condition scoring. › Behavioral observations. › Recordkeeping and data analysis.
  • 8. DIAGNOSIS Diagnosis plays a crucial role in ensuring animal welfare and upholding ethical research practices. It involves identifying the cause of an animal's illness or distress. The several aspects of diagnosis under CPCSEA include:  Clinical examination.  Diagnostic tests: Blood tests, imaging techniques like X-rays or ultrasound.  Differential diagnosis.  Consulting specialists.  Animal welfare considerations.  Documenting the diagnosis. By promoting effective diagnostic practices, the CPCSEA strives to ensure that animals used in research receive timely and accurate medical attention.
  • 9. TREATMENT AND CONTROL OF DISEASE CPCSEA extends to the effective treatment and control of diseases within animal facilities. The various steps how CPCSEA guidelines address this crucial aspect: 1. Proactive Disease Prevention. 2. Prompt Diagnosis and Treatment. 3. Hygiene and Sanitation. 4. Recordkeeping and Reporting. 5. Collaboration and Training: Veterinarians/researchers, Training of animal caring staff.
  • 10. CONT… PROACTIVE DISEASE PREVENTION › Vaccination › Parasite control › Nutritional management › Environmental enrichment PROMPT DIAGNOSIS AND TREATMENT › Daily monitoring › Qualified veterinary care › Appropriate medication › Pain management › Isolation and quarantine
  • 11. PERSONAL HYGIENE Maintaining high standards of personal hygiene is an essential aspect of animal welfare under the CPCSEA. This not only protects the animals from potential infections but also ensures the validity of research data. The various aspects for personal hygiene as followings: › Clean clothing, footwear and Hand hygiene. › Jewellery and accessories. › Eating, drinking, smoking, hair and beard. › Protective equipment, Training and awareness. › Facilities and supplies. The CPCSEA aims to foster a culture of personal hygiene within animal research facilities.
  • 12. LOCATION OF ANIMAL FACILITIES TO LABORATORIES The CPCSEA lays down specific guidelines for the location of animal facilities relative to laboratories. This aims to minimize stress, noise, and other disturbances for the animals while ensuring research integrity and practicality. The various key requirements: 1) Physical Separation: Separate building, wing, floor, or room, Distance from disturbance. 2) Dedicated Access: Separate pathways, entrances and controlled access points. 3) Environmental Considerations: Natural light, ventilation, Temperature, humidity control and noise reduction. 4) Additional Guidelines: Waste disposal, Security and emergency preparedness.
  • 13. ANESTHESIA Anesthesia plays a crucial role in achieving goal by ensuring animals are pain-free and unconscious during painful procedures or surgeries. The CPCSEA lays down specific guidelines for the use of anesthesia in animals: › Justification and minimization. › Qualified personnel. › Pre-anesthetic assessment, Appropriate anesthetic agents and dosages. › Pain management: An integral part of anesthesia. › Monitoring and recordkeeping. › Recovery and post-operative care. › Training and education.
  • 14. CONT… Anesthesia is a controlled, temporary state of unconsciousness, painlessness, and muscle relaxation induced in animals through medication. The different types of anesthesia can be used in animals, including: a) General anesthesia: This induces complete unconsciousness and muscle relaxation, often through inhaled gases or injectable medications. b) Local anesthesia: This numbs a specific area of the body, allowing for procedures on that area while the animal remains conscious. c) Regional anesthesia: This numbs a larger area of the body, such as a limb, while the animal remains conscious or lightly sedated.
  • 15. Species: Rodent (rat or mouse) Procedure: Tissue collection Agent: Ketamine/xylazine combination (injectable) Dosage: Ketamine 80-100 mg/kg, xylazine 5-10 mg/kg, both given intraperitoneally Species: Rabbit Procedure: Dental cleaning Agent: Propofol (injectable) Dosage: 5-10 mg/kg intravenous bolus, followed by a maintenance infusion of 1-5 mg/kg/hr Species: Cat Procedure: Ovariohysterectomy (spaying) Agent: Ketamine (injectable) and medetomidine (injectable) Dosage: Ketamine 5-10 mg/kg, medetomidine 0.05-0.1 mg/kg, both given intramuscularly Species: Horse Procedure: Colic surgery Agent: Sevoflurane (inhaled gas) and epidural analgesia (local anesthetic) Dosage: Sevoflurane 1-3% in oxygen, epidural bupivacaine 0.5- 1.0 ml/segment Species: Dog Procedure: Neutering Agent: Isoflurane (inhaled gas) Dosage: 1-3% isoflurane in oxygen, adjusted based on individual response SPECIFIED E X A M P L E S
  • 16. EUTHANASIA Euthanasia refers to the intentional act of ending an animal's life to relieve suffering or prevent further pain. Purpose: The euthanasia having several purposes as followings: › Painless death. › Relief from suffering. › Population control. Euthanasia is a sensitive and ethical decision. Methods: Various methods can be employed for euthanasia. These are like: Overdose of anesthetic agents, Cervical dislocation, Carbon dioxide (CO2) inhalation and barbiturate injection or electrocution.
  • 17. PHYSICAL FACILITIES CPCSEA to ensure the animals' physical and mental well-being, minimizing stress and promoting their health and comfort. The various key aspects of physical facilities for animals under CPCSEA: › Caging and housing. › Environmental sanitation and hygiene. › Food and water: Nutritious diet, Fresh water. › Veterinary care. › Recordkeeping. Animal facilities can create a safe, comfortable, and stimulating environment for animals used in research.
  • 18. ENVIRONMENT CPCSEA recognizes the importance of a stimulating and stress-free environment for animals used in research. The key aspects of environment for animals under CPCSEA: 1. Sensory stimulation. 2. Social interaction. 3. Choice and control. 4. Species-specific considerations. 5. Regular monitoring and evaluation. These guidelines for environmental enrichment to promote the animals' physical and mental well-being.
  • 19. ANIMAL HUSBANDRY Animal husbandry practices for animals used in research fall under the strict guidelines of the CPCSEA. These guidelines aim to ensure ethical treatment, good welfare, and minimal suffering for animals throughout their involvement in research. How animal husbandry practices are addressed under CPCSEA: › Housing and environment: Species-specific, temp. Humidity and Lighting cycles › Food and water › Hygiene and sanitation › Veterinary care and record keeping.
  • 20. RECORD KEEPING The Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) places great emphasis on meticulous record keeping throughout all stages of animal research. › Detailed records: Maintain detailed records of all animal care procedures, including housing conditions, diet, veterinary care, observations, and any abnormalities. This ensures proper monitoring and animal well-being. › Animal identification: Each animal should have proper identification tags or other methods to track individual health and well-being.
  • 21. SOPs CPCSEA emphasizes the importance of standardized procedures to ensure the ethical treatment and welfare of animals in research. These SOPs cover various aspects of animal care and use, from housing and husbandry to experimental procedures and recordkeeping. The key areas where SOPs are crucial under CPCSEA guidelines: › Animal Acquisition and Housing › Institutional Animal Ethics Committee (IAEC). › Animal Housing and Husbandry. › Animal Experimentation: For drugs, emergency protocols etc. › Recordkeeping and Documentation. SOPs are not static documents. They should be regularly reviewed, updated, and adapted based on new scientific knowledge, changes in animal welfare best practices, and evolving regulatory requirements.
  • 22. CONT… › SOPs stands for Standard Operating Procedures. These are detailed, step-by-step instructions that outline how specific tasks related to animal care and use should be carried out. › They are essential for ensuring the consistent, ethical, and humane treatment of animals throughout their involvement in research.
  • 23. PERSONNELAND TRAINING The CPCSEA recognizes the crucial role of qualified and well-trained personnel in ensuring the ethical treatment and well-being of animals used in research. These individuals are responsible for various aspects of animal care, from husbandry and handling to experimental procedures and recordkeeping. › Qualifications and experience: Animal care personnel, Researchers and technicians and Veterinarians. › Training requirements: Regular refresher training and Specialized Training. › Training content and delivery. Qualified and well-trained personnel are not just an expense but an investment in ethical research and animal welfare.
  • 24. TRANSPORT OF LAB ANIMALS The transport of laboratory animals brings unique challenges and ethical considerations. Ensuring their safety, comfort, and well-being during transportation is crucial. CPCSEA outlines specific guidelines to ensure responsible and humane practices in this process. The various key aspects to consider for the transport of lab animals under CPCSEA:  Planning and preparation.  Transportation containers and environment.  Animal handling and care.  Post-transport care.  Adherence to regulations. Responsible transport of lab animals requires careful planning, adherence to ethical principles, and prioritizing animal welfare throughout the process.
  • 25. REFERECES 1. Committee for the Purpose of Control and Supervision on Experiments on Animals. (2003). CPCSEA Guidelines for laboratory animal facility. Indian J Pharmacol, 35(4), 257-274. 2. Mahesh, N. M. IMPACT OF ‘CPCSEA’GUIDELINES ON LABORATORY ANIMALS USE. 3. Pereira, S., Veeraraghavan, P., Ghosh, S., & Gandhi, M. (2004). Animal experimentation and ethics in India: the CPCSEA makes a difference. Alternatives to laboratory animals, 32(1_suppl), 411-415. 4. Qadri, S. S., & Ramachandra, S. G. (2018). Laws, regulations, and guidelines governing research animal care and use in India. In Laboratory animals (pp. 237-261). Academic Press.